
The episode features Amir Hayeri discussing the use of AI in predicting glucose trends and the implications for diabetes management.
We talk with Amir Hayeri, founder and CEO of BioConscious Technologies, about using machine learning to predict glucose trends and turn CGM streams into actionable clinical foresight. We dig into accuracy, trust, liability, and why clustering dysglycemia may reveal risk that HbA1c can miss. • Amir’s origin story and the prevention-first philosophy behind BioConscious • Predicting glucose 60 minutes ahead using CGM data and how accuracy is measured • Why an app without a clin...
Explore listener stats, chart rankings, contacts and more on the Diabetes Technology Report podcast page.